RLX Technology Inc
F:3CM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
RLX Technology Inc
F:3CM
|
CN |
|
Agatos SpA
F:5JS1
|
IT |
|
A
|
Altius Minerals Corp (AB)
F:VTM
|
CA |
|
C
|
Castleview Property Fund Ltd
JSE:CVW
|
ZA |
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
Sats ASA
F:2S0
|
NO |
|
P
|
Prabos Plus as
PSE:PRAB
|
CZ |
|
Summerway Capital PLC
LSE:SWC
|
UK |
|
Z
|
Zhejiang Xinao Textiles Inc
SSE:603889
|
CN |
|
New Pacific Metals Corp
F:3N7A
|
CA |
|
Flughafen Wien AG
F:FLW1
|
AT |
|
C
|
Corebridge Financial Inc
F:AS5
|
US |
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
A
|
Alphabet Inc
XMUN:ABEA
|
US |
|
T
|
Tsakos Energy Navigation Ltd
F:TK41
|
GR |
RLX Technology Inc
RLX Technology makes e-vapor products, including electronic cigarettes and replacement pods and cartridges. The company’s main business is designing, manufacturing, and selling these devices and consumables to adult smokers and vape users, mainly through retail channels and distributors in China. It earns money when consumers buy hardware and, more importantly, when they keep buying refill products that need regular replacement. The company sits in the nicotine product chain between manufacturing and retail. It does not grow tobacco or run stores; instead, it focuses on product design, supply chain control, and branded e-vapor hardware and consumables. That makes its business model closer to a consumer products company than a traditional tobacco producer, because repeat purchases of pods and related accessories are the main driver of demand. RLX’s role in the industry is shaped by regulation, product safety rules, and changing consumer preferences. Its success depends on keeping products compliant, widely available, and attractive to adult users who want an alternative to combustible cigarettes. In simple terms, RLX sells regulated nicotine devices and the refill items that go with them, and it makes money every time those products move through its retail and distribution network.
RLX Technology makes e-vapor products, including electronic cigarettes and replacement pods and cartridges. The company’s main business is designing, manufacturing, and selling these devices and consumables to adult smokers and vape users, mainly through retail channels and distributors in China. It earns money when consumers buy hardware and, more importantly, when they keep buying refill products that need regular replacement.
The company sits in the nicotine product chain between manufacturing and retail. It does not grow tobacco or run stores; instead, it focuses on product design, supply chain control, and branded e-vapor hardware and consumables. That makes its business model closer to a consumer products company than a traditional tobacco producer, because repeat purchases of pods and related accessories are the main driver of demand.
RLX’s role in the industry is shaped by regulation, product safety rules, and changing consumer preferences. Its success depends on keeping products compliant, widely available, and attractive to adult users who want an alternative to combustible cigarettes. In simple terms, RLX sells regulated nicotine devices and the refill items that go with them, and it makes money every time those products move through its retail and distribution network.
Revenue growth: RLX reported second-quarter net revenue of RMB 1.01 billion, up 14.8% year over year, with international markets again driving most of the growth.
Margins: Gross margin expanded sharply in the quarter, helped by supply chain optimization, better manufacturing yields, and a favorable mix, but management said some of that strength should normalize in the second half.
Europe expansion: The company leaned harder into Western Europe, including a controlling investment in a major distributor that will be consolidated starting in Q3 2026 and should lift reported international growth.
Capital discipline: Management said it will keep prioritizing organic growth, selective M&A, and shareholder returns, with acquisitions judged on payback, accretion, and strategic fit rather than a fixed valuation cap.
U.S. and China: RLX remains cautious on the U.S. until the regulatory path is clearer, while it sees tighter enforcement against illegal e-cigarettes in Mainland China as a long-term positive but expects full-year sales there to be broadly flat.
New categories: Management positioned modern oral nicotine pouches as a major growth driver and said Southeast Asia manufacturing capacity is being built to support multi-category expansion.